When the caregiver role starts to feel like a second skin

Caregiving is no longer something I do. It is part of the way I exist.

Written by Samuel Ike |

Banner image for Samuel Ike's column

I catch myself scanning the room for hazards before I even sit down.

The loose edge of a rug, the distance between the chair and the wall, the height of the step onto the veranda — all of it registers automatically. I do not decide to notice these things anymore. The awareness simply happens, the way breathing does. At some point during the years of caring for my mum, the role of caregiver has settled over me like a second skin.

It was not always this way. In the first months after her myeloma diagnosis, I still had to remind myself to check the medication list, to watch for new symptoms, to prepare for the next appointment. The tasks felt external, something I took on each morning and tried to set down at night. Over time the separation disappeared. The vigilance, quiet calculations, and constant readiness became part of how I move through ordinary hours.

Recommended Reading
A researcher looks at samples through a microscope sitting alongside a beaker and a rack of filled vials.

Under-the-skin myeloma therapy shows strong responses in Phase 2 trial

Embracing the skin I live in now

I notice the change most clearly in small moments.

When I am out buying groceries, I automatically choose foods that will be easy for her to manage. When I hear a medical term on the radio, my mind translates it into practical implications for our household. When I lie down at night, part of my attention remains tuned to the sounds from her room. The role does not switch off simply because the day has ended.

This second skin has both costs and unexpected gifts. It can feel heavy. There are evenings when I long for the lighter version of myself that existed before myeloma entered our lives — the one who could leave the house without a mental checklist, who could sleep without one ear open. At the same time, the settled awareness has made me more attentive, more patient, more capable of reading subtle shifts in her condition before they become crises.

I no longer fight the way the role has reshaped me. Instead, I try to wear it with as much gentleness as possible. I allow myself short moments of distance when I can, knowing that the second skin will still be there when I return. I notice the ways it has deepened my capacity for care without erasing every other part of who I am. The balance is imperfect, but it is honest.

There are days when the second skin feels almost natural.

I move through the routines of medication, meals, and quiet companionship without the earlier sense of strain. The role and the self have become harder to tell apart. On those days, I simply accept the merging. Caregiving is no longer something I do. It is part of the way I exist in relation to the person I love.

I still remember the man I was before this skin formed. He is not gone. He appears in brief moments of laughter, in the pleasure of a solitary walk, in the rare stretch of hours when responsibility loosens its hold. Yet even then the second skin remains close, ready to be worn again the moment it is needed.

In the end, I have stopped waiting for the old version of myself to return unchanged. This is the skin I live in now — shaped by years of attention, marked by both fatigue and deep attachment. It is not the life I once imagined, but it is the life I am learning to inhabit with care.


Note: Rare Cancer News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Rare Cancer News or its parent company, Bionews, and are intended to spark discussion about issues pertaining to rare cancer.

Leave a comment

Fill in the required fields to post. Your email address will not be published.

Comments are moderated. Once approved, your comment and username will be publicly visible. Please avoid sharing personal health information or other sensitive details.